Bioxcel Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $112k | 44k | 2.56 |
| 2025-06-30 | $72k | 40k | 1.81 |
| 2025-03-31 | $207k | 102k | 2.03 |